Corvex, Inc.: enters at-the-market sales agreement

What happened On Oct 14, 2026, Corvex, Inc. entered into an At-the-Market Sales Agreement (the “Sales Agreement”) with Chardan Capital Markets LLC, as sales agent and, during the applicable exclusive period, as exclusive sales agent, under which the Company may offer and sell, from time to time through or to the Agent, shares of its common stock, par value $0.0001 per share (the “Shares”).

Under the Sales Agreement, the Agent may sell Shares by any method permitted by law that qualifies as an “at the market offering” under Rule 415(a)(4). The Company has no obligation to sell any Shares and may suspend offers at any time. The Company will pay the Agent a commission of 2.5% of the aggregate gross proceeds and will reimburse the Agent for legal fees up to $75,000 in connection with execution, up to $10,000 per calendar quarter thereafter, and up to $30,000 for each additional program “refresh.” The Company stated it intends to use net proceeds for working capital and general corporate purposes. The Shares are being offered pursuant to the Company’s effective shelf registration statement on Form S-3 (File No. 333-298769), declared effective by the SEC on Sep 16, 2026, and a prospectus supplement dated Oct 14, 2026 filed under Rule 424(b)(5) on Oct 14, 2026.

Key details

• Date entered: Oct 14, 2026; counterparty: Chardan Capital Markets LLC.
• Offering type: at-the-market offering under Rule 415(a)(4).
• Agent compensation: 2.5% commission on aggregate gross proceeds.
• Legal fee reimbursements: up to $75,000 at execution; $10,000 per calendar quarter; $30,000 per program refresh.

Why it may matter This report is Item 1.01 (entry into a material definitive agreement), which covers the Sales Agreement under which the Company may sell shares through an at-the-market offering. The filing does not show why the company entered into the agreement.